Januray 26, 2010
Radient Pharmaceuticals Submits Business Plan For Continued NYSE AMEX Listing » More
December 28, 2009
Radient Pharmaceuticals Informed by AMEX of Possible Delisting » More
December 22, 2009
Radient Pharmaceuticals Announces 2010 Business Plan For Its AMDL Diagnostic Subsidiary » More
December 18, 2009
Radient Pharmaceutical China Pharma Division Has Put In Place A Strategic Adivosry Agreement With Security Research Associates To Assist With The Sale or Financing of Jade Pharmaceutical »More
|